Subscribe

Germany’s CureVac raises $213 million in IPO boosted by pandemic

Share Video

German coronavirus vaccine developer CureVac says its New York share market debut has netted more than €180 million. Its shares sold at the top end in Friday's placing on the Nasdaq exchange.

Tags

More From Guardian TV

Don't Miss

Immigration in Germany and the challenge of integration

Immigration in Germany and the challenge of integration

What's wrong with Germany's economy?

What’s wrong with Germany’s economy?